- Home
- NATR vs NLSP Comparison
NATR vs NLSP Comparison
Compare NATR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- NLSP
- Stock Information
- Founded
- NATR 1972
- NLSP 2015
- Country
- NATR United States
- NLSP Switzerland
- Employees
- NATR N/A
- NLSP N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- NLSP Health Care
- Exchange
- NATR Nasdaq
- NLSP Nasdaq
- Market Cap
- NATR 254.1M
- NLSP 243.8M
- IPO Year
- NATR N/A
- NLSP 2021
- Fundamental
- Price
- NATR $13.16
- NLSP $5.06
- Analyst Decision
- NATR Strong Buy
- NLSP
- Analyst Count
- NATR 2
- NLSP 0
- Target Price
- NATR $19.50
- NLSP N/A
- AVG Volume (30 Days)
- NATR 32.7K
- NLSP 26.6K
- Earning Date
- NATR 11-05-2024
- NLSP 10-18-2024
- Dividend Yield
- NATR N/A
- NLSP N/A
- EPS Growth
- NATR 191.23
- NLSP N/A
- EPS
- NATR 0.79
- NLSP N/A
- Revenue
- NATR $441,682,000.00
- NLSP N/A
- Revenue This Year
- NATR $0.59
- NLSP N/A
- Revenue Next Year
- NATR $4.12
- NLSP N/A
- P/E Ratio
- NATR $16.58
- NLSP N/A
- Revenue Growth
- NATR 2.14
- NLSP N/A
- 52 Week Low
- NATR $10.81
- NLSP $4.08
- 52 Week High
- NATR $21.72
- NLSP $40.60
- Technical
- Relative Strength Index (RSI)
- NATR 44.34
- NLSP 41.04
- Support Level
- NATR $12.97
- NLSP $4.72
- Resistance Level
- NATR $14.18
- NLSP $5.50
- Average True Range (ATR)
- NATR 0.41
- NLSP 0.64
- MACD
- NATR -0.02
- NLSP 0.03
- Stochastic Oscillator
- NATR 15.70
- NLSP 34.17
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.